Skip to main content

Find Clinical Trials

Home
Conditions
HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis

Clinical trial condition

HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis

Explore clinical trials studying HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis trial results

Recruiting

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

NCT07203729

Conditions: Breast Diseases, Breast Neoplasms, HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis, +4 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details